The Role of Biomarkers in the Treatment of Alcohol Use Disorders

Substance Abuse Treatment Advisory, The Role of Biomarkers in the Treatment of Alcohol Use Disorders
Volume 5, Issue 4, September 2006.
This Advisory presents current information on biomarkers, which are physiological measurements that can indicate alcohol exposure or consumption. The Advisory discusses the use and role of biomarkers in treatment, their limitations, and the pros and cons of each biomarker. It presents information on well-known markers, including the liver enzymes and mean corpuscular volume. Newer markers, such as carbohydrate-deficient transferrin (CDT) and phosphatidyl ethanol (PEth), are also discussed. Information on controversial markers such as ethyl glucuronide (EtG) and ethyl sulfate (EtS) is presented. When used in conjunction with patient interviews and screening tools, these measures can provide valuable information about a patient’s alcohol use. DHHS Publication No. (SMA) 06-4223 NCADI Publication No. MS996

1/1/2006 12:00:00 PM

Price: $0.00
Inventory Number: MS996